Corient Private Wealth LP Purchases Shares of 679,511 Envista Holdings Corporation $NVST

Corient Private Wealth LP purchased a new position in Envista Holdings Corporation (NYSE:NVST) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 679,511 shares of the company’s stock, valued at approximately $17,905,000.

Several other institutional investors have also recently made changes to their positions in the stock. Royal Bank of Canada grew its stake in shares of Envista by 26.6% during the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock valued at $401,000 after acquiring an additional 4,885 shares during the period. Millennium Management LLC raised its stake in Envista by 218.6% during the 1st quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock worth $6,627,000 after acquiring an additional 263,442 shares during the period. Goldman Sachs Group Inc. lifted its holdings in Envista by 39.3% during the first quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock valued at $10,859,000 after purchasing an additional 177,630 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Envista by 15.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after purchasing an additional 76,246 shares in the last quarter. Finally, Prudential Financial Inc. boosted its position in shares of Envista by 22.1% in the second quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock worth $367,000 after purchasing an additional 3,395 shares during the period.

Insiders Place Their Bets

In related news, SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the sale, the senior vice president owned 27,321 shares of the company’s stock, valued at $751,327.50. This represents a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.99% of the company’s stock.

Envista Stock Performance

NYSE NVST opened at $27.15 on Friday. The stock has a market capitalization of $4.36 billion, a PE ratio of 46.81, a P/E/G ratio of 1.31 and a beta of 0.86. The business has a 50 day simple moving average of $27.12 and a two-hundred day simple moving average of $26.38. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. Envista Holdings Corporation has a 1-year low of $18.77 and a 1-year high of $30.42.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.07. The business had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, research analysts predict that Envista Holdings Corporation will post 1.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on NVST shares. Weiss Ratings raised shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 6th. Evercore reaffirmed an “outperform” rating and issued a $33.00 target price on shares of Envista in a report on Thursday, May 7th. Barclays cut their price target on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, June 11th. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 22nd. Finally, Mizuho set a $29.00 price objective on Envista in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $29.31.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.